Mitsui Chemicals Group and ARRK Thailand to Organize the First MotionTech 2024 Exhibition
Showcasing the materials and technology for future mobility BANGKOK--(BUSINESS WIRE)--#ARRK--Mitsui Chemicals Asia Pacific (MCAP) –…
2 years ago
3,000 ITE students to be equipped with workplace skills and competencies under Prudential’s talent engagement programme
SINGAPORE - Media OutReach Newswire - 9 February 2024 - On 8 February 2024, Prudential…
2 years ago
PropertyGuru Group Limited to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2023
SINGAPORE--(BUSINESS WIRE)--PropertyGuru Group Limited (NYSE: PGRU) (“PropertyGuru†or “the Companyâ€), Southeast Asia’s leading1 property technology…
2 years ago
Bright Day Divorce Consultancy Announced Expansion plans into the Greater Bay Area
HONG KONG SAR - Media OutReach Newswire - 9 February 2024 - Since 2013, Bright…
2 years ago
WealthReach Finance to Improve Customer Experience with AI and Digital Communications
HONG KONG SAR - Media OutReach Newswire - 9 February 2024 - In the face…
2 years ago
Wenchang, Hainan Takes Flight as the Visionary “City of the Future” Igniting a Thriving Aerospace Industry
WENCHANG, CHINA - Media OutReach Newswire - 9 February 2024 - On January 17th 2024,…
2 years ago
King Power Celebrates the Beginning of The New Year with A Dazzling “Kingdom of Dragons” Experience “King Power Chinese New Year 2024”
BANGKOK, THAILAND - Media OutReach Newswire - 9 February 2024 - King Power marks the…
2 years ago
Recruit Holdings to Announce Third Quarter FY2023 Results on Feb 9 JST
TOKYO--(BUSINESS WIRE)--Recruit Holdings Co., Ltd. (TSE 6098) will be reporting the the third quarter financial…
2 years ago
E.A. Gibson and SOGDC Sign MoU for the Joint Development of Oil and Gas Facilities Project at Sipitang Oil & Gas Industrial Park (SOGIP)
LONDON--(BUSINESS WIRE)--E.A. Gibson Shipbrokers Ltd (Gibson) and Sabah Oil & Gas Development Corporation Sdn Bhd…
2 years ago
Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024
− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial…
2 years ago